By Laura Pole, RN, MSN
February 18, 2019

From five kinds of evidence that men with cancer use in guiding decisions about complementary approaches to care, researchers found that patients put the most stock in personal stories and the least priority on rigorous scientific evidence.1 Health professionals tend to reverse this hierarchy of evidence.

Finding common ground can be challenging.

The Landscape

We have found that sites mentioning integrative cancer therapies typically fall in four broad categories:

  • Sites from large medical centers, academia and government
  • Commercial...
Read more
Breast Cancer Prevention Women
By The Institute for Natural Medicine

Emphasizing a holistic approach, naturopathic medicine offers complementary natural therapies to support and strengthen the body and mind before, during, and after conventional medical breast cancer treatment. Naturopathic medicine can help optimize tolerance to conventional treatments while also providing strategies to reinforce the body’s natural defenses and recovery systems so that each individual is at their strongest capacity to fight the disease.

One out of eight women in the United States will develop breast cancer over the course of her lifetime, and while rare, breast...

Read more
DNA Strand
By Tina Kaczor, ND, FABNO

The FDA has recently approved the first direct-to-consumer reporting of a germline mutation for cancer risk—specifically, three BRCA gene mutations tested by 23andme.

Understandably, this has garnered a lot of media attention.

All practitioners should know that there are several caveats to this approval.

According to the FDA, "The test only detects three out of more than 1,000 known BRCA mutations. This means a negative result does not rule out the possibility that an individual carries other BRCA mutations that increase cancer risk."

Also according to the FDA...

Read more
By Jacob Schor, ND, FABNO

While we might wish to say that naturopathic medicine is evidence based, we must admit that some of our thoughts regarding patient treatment rely more on best guesses based on relatively scant evidence. We often find ourselves extrapolating from faint data points hoping to find a useful path forward. Here’s a recent example:

Just before Christmas, in December 2016, a paper by Bouchard et al, a group of researchers from Quebec, Canada, was published in the International Journal of Radiation Biology that caught our attention. These researchers reported that radiation of...

Read more